284 related articles for article (PubMed ID: 20620632)
1. Transtympanic Ringer's lactate application in the prevention of cisplatinum-induced ototoxicity in a chinchilla animal model.
Munguia R; Sahmkow SI; Funnell WR; Daniel SJ
Otolaryngol Head Neck Surg; 2010 Jul; 143(1):134-40. PubMed ID: 20620632
[TBL] [Abstract][Full Text] [Related]
2. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate.
Choe WT; Chinosornvatana N; Chang KW
Otol Neurotol; 2004 Nov; 25(6):910-5. PubMed ID: 15547419
[TBL] [Abstract][Full Text] [Related]
3. Ototoxicity of topical moxifloxacin in a chinchilla animal model.
Daniel SJ; Duval M; Sahmkow S; Akache F
Laryngoscope; 2007 Dec; 117(12):2201-5. PubMed ID: 18322423
[TBL] [Abstract][Full Text] [Related]
4. Is ototopical nystatin ototoxic? A chinchilla model.
Daniel SJ; Sahmkow S; Akinpelu OV
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1022-4. PubMed ID: 21860059
[TBL] [Abstract][Full Text] [Related]
5. Oxymetazoline ototoxicity in a chinchilla animal model.
Daniel SJ; Akinpelu OV; Sahmkow S; Funnell WR; Akache F
Otolaryngol Head Neck Surg; 2012 Jan; 146(1):114-8. PubMed ID: 21846927
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs.
Daldal A; Odabasi O; Serbetcioglu B
Otolaryngol Head Neck Surg; 2007 Nov; 137(5):747-52. PubMed ID: 17967639
[TBL] [Abstract][Full Text] [Related]
8. Ototoxicity of triethanolamine polypeptide (cerumenex) in the chinchilla.
Daniel SJ; Sahmkow SI; Munguia R; Schloss M; Akache F
Laryngoscope; 2008 Mar; 118(3):478-82. PubMed ID: 18090863
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of erdosteine against cisplatin-induced ototoxicity in a guinea pig model.
Waissbluth S; Dupuis I; Daniel SJ
Otolaryngol Head Neck Surg; 2012 Apr; 146(4):627-32. PubMed ID: 22051542
[TBL] [Abstract][Full Text] [Related]
10. Ototoxicity of baby oil in a chinchilla animal model.
Al-Jarallah A; Akinpelu OV; Citra D; Daniel SJ
Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):564-8. PubMed ID: 22348846
[TBL] [Abstract][Full Text] [Related]
11. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
Sockalingam R; Freeman S; Cherny TL; Sohmer H
Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions.
Hatzopoulos S; Di Stefano M; Campbell KC; Falgione D; Ricci D; Rosignoli M; Finesso M; Albertin A; Previati M; Capitani S; Martini A
Audiology; 2001; 40(5):253-64. PubMed ID: 11688544
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the ototoxicity of almond oil in a chinchilla animal model.
Peleva E; Mourad S; Citra D; Daniel SJ
Laryngoscope; 2011 Dec; 121(12):2661-4. PubMed ID: 22109768
[TBL] [Abstract][Full Text] [Related]
14. Effect of Transtympanic Injection of Melatonin on Cisplatin-Induced Ototoxicity.
Demir MG; Altıntoprak N; Aydın S; Kösemihal E; Başak K
J Int Adv Otol; 2015 Dec; 11(3):202-6. PubMed ID: 26915150
[TBL] [Abstract][Full Text] [Related]
15. Middle ear instillation of gentamicin and streptomycin in chinchillas: morphologic appraisal of selective ototoxicity.
Chen JM; Kakigi A; Hirakawa H; Mount RJ; Harrison RV
J Otolaryngol; 1999 Jun; 28(3):121-8. PubMed ID: 10410341
[TBL] [Abstract][Full Text] [Related]
16. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
Knight KR; Kraemer DF; Winter C; Neuwelt EA
J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
[TBL] [Abstract][Full Text] [Related]
17. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.
Biro K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Oncology; 2006; 70(3):177-84. PubMed ID: 16757924
[TBL] [Abstract][Full Text] [Related]
19. Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model.
Dille MF; McMillan GP; Reavis KM; Jacobs P; Fausti SA; Konrad-Martin D
J Acoust Soc Am; 2010 Sep; 128(3):1163-74. PubMed ID: 20815453
[TBL] [Abstract][Full Text] [Related]
20. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
Nader ME; Théorêt Y; Saliba I
Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
